Trial intelligence / Profile preview

BLI4900 (Suflave) vs Suprep for Colonoscopy Preparation

NCT04446312Phase 3Completed

Sponsor
Braintree Laboratories
Start
Jul 2020
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of magnesium sulfate in bowel preparation (2 arms), sponsored by Braintree Laboratories. Primary endpoint: Proportion of Subjects With Successful Bowel Preparation at 2 days. Started Jul 2020; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT04446312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04446312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call